| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data were presented as mean ± SD or number (%). Gr1: nonsmokers group; Gr2: current-smokers group; Gr3: past-smokers group; POD1: postoperative day one; POD2: postoperative day two; POD3: postoperative day three; PONV: postoperative nausea and vomiting; VASM: visual analogue scales on movement; VASR: visual analogue scales at rest; DOSE: postoperative morphine consumption; : when compared with nonsmokers or past-smokers. Controlling for age, weight, and surgical duration when dependent variable is DOSE; controlling for age and surgical duration when dependent variable is VASM and VASR. |
Research Article
The Implications of Tobacco Smoking on Acute Postoperative Pain: A Prospective Observational Study
Table 4
Comparisons for postoperative outcomes on male patients.